跳至主要内容
临床试验/NCT01315587
NCT01315587Unknown2 期

A Double-blind Placebo Controlled Trial the Comparison of Effectiveness of Repetitive TMS and iTBS on Negative Symptoms and Cognition in Patients With Schizophrenia

University of Tehran2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
2 期
入组人数
30
试验地点
2
主要终点
Positive and negative syndrome scale ( PANSS )

研究概览

简要总结

The pilot studies have showed that theta burst stimulation (TBS) can have the more rapid and durable effects to the apply traditional rTMS protocols. The aim of this study is to investigate the effect of repetitive TMS and theta burst in reduction of negative symptoms and remission of cognitive functioning in patients with schizophrenia. In a randomized, double blind clinical trials, 30 patients with schizophrenia in Razi psychiatric hospital will be assigned to receive repetitive TMS; theta burst, or sham TMS, daily; for 20 sessions. The negative symptoms and cognitive functioning will be assessed before the treatment (pre test) during the treatment (session 10), and after the treatment (post test).QEEG and LORETA apply before and after rTMS in all subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Outpatients male and female with the range of 18-50 years of age
  • The diagnosis of schizophrenia according to DSM-IV-TR
  • Completion of consent form
  • Being under supervision of a psychiatrist,
  • Being able to adhere to treatment schedule,
  • Having stable symptoms as defined by not requiring a change in antipsychotic medication for at least 4 weeks or at least 2 weeks for psychotropic agents prior to entering the Study

排除标准

  • The history of rTMS treatment for any reason
  • Cardiac pacemaker
  • Acute heart attack
  • The risk of seizure with any reasons
  • The history of epilepsy or seizure in the first relatives
  • Any metal in head
  • Brain trauma
  • Breastfeeding
  • Drug dependency

结局指标

主要结局

Positive and negative syndrome scale ( PANSS )

时间窗: Change of baseline in negative symptoms at 20 sessions

次要结局

  • Calgary depression for schizophrenia scale (CDSS)(3 times (Before treatment, session 10, immediately after treatment))
  • Schizophrenia quality of life scale (SQLS)(3 times (Before treatment, session 10, immediately after treatment))
  • Cantab Schizophrenia Battery(3 times (Before treatment, session 10, immediately after treatment))
  • QEEG and low resolution brain electromagnetic tomography (LORETA)(3 times (Before treatment,session 10, immediately after treatment))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

reza kazemi

Researcher

University of Tehran

研究点 (2)

Loading locations...

相似试验